Recombinant VEGFR2 (Pulocimab Biosimilar) antibody

Catalog No. ABIN7829552

The Humanized Monoclonal anti-VEGFR2 (Pulocimab Biosimilar) antibody is suitable to detect VEGFR2 (Pulocimab Biosimilar) in samples from Human.

Quick Overview for Recombinant VEGFR2 (Pulocimab Biosimilar) antibody (ABIN7829552)

Target: VEGFR2 (Pulocimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This VEGFR2 (Pulocimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-VEGFR2 (Pulocimab Biosimilar) Antibody

Purpose: Anti-VEGFR2(pulocimab biosimilar) mAb

Isotype: IgG1

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for VEGFR2 (Pulocimab Biosimilar)

Target: VEGFR2 (Pulocimab Biosimilar)

Alternative Name: Pulocimab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:FLK1,CD309,VEGFR,VEGFR2
Synonyms Antibody:AK-109, AK109,AK 109

UniProt: P35968